Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibaut Jamme

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2025
Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBDSahira Chaiben, Peggy Gandia, Thibaut Jamme, et al.
Orphanet Journal of Rare Diseases|May 26, 2025
Advanced strategies for detecting acid sphingomyelinase deficiency type B with attenuated phenotypesThomas Villeneuve, Thibaut Jamme, Robin Schwob, et al.
Scientific Reports|July 11, 2025
Multidimensional reference regions is a new tool to optimize the personalized care of patientsPeggy Gandia, Angélo Faget, Thibaut Jamme, et al.
Clinical Biochemistry|June 25, 2024
Unexpected discovery of CRP analytical interference: A case reportVallauris Meslé, Eva Bories, Chloé Bost, et al.
Infectious Diseases Now|March 18, 2025
Early suPAR levels as a predictor of COVID-19 severity: A new tool for efficient patient triagePauline Nègre, Didier Tayac, Thibaut Jamme, et al.
Infectious Diseases Now|February 3, 2024
Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infectionGauthier Lignier, Caroline Camaré, Thibaut Jamme, et al.
La Revue De Medecine Interne|June 18, 2026
[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health]Guillaume Labarthe, Anne Galinier, Florence Rulquin, et al.
Diagnostic Microbiology and Infectious Disease|September 16, 2023
Evaluation of two anti-SARS-CoV-2 antibody immunoassays for monitoring patients on pre-exposure prophylaxisCamille Vellas, Chloé Dimeglio, Emma Joncour, et al.
Journal of Medical Virology|October 8, 2022
Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infectionMarion Migueres, Sabine Chapuy-Regaud, Marcel Miédougé, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 28, 2025
Optimization and stability evaluation of a pediatric spironolactone oral suspension: Formulation development and analytical validationRoxanne Desquines, Zoubeir Ramjaun, Acil Jaafar, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2025
Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBDSahira Chaiben, Peggy Gandia, Thibaut Jamme, et al.
Orphanet Journal of Rare Diseases|May 26, 2025
Advanced strategies for detecting acid sphingomyelinase deficiency type B with attenuated phenotypesThomas Villeneuve, Thibaut Jamme, Robin Schwob, et al.
Scientific Reports|July 11, 2025
Multidimensional reference regions is a new tool to optimize the personalized care of patientsPeggy Gandia, Angélo Faget, Thibaut Jamme, et al.
Clinical Biochemistry|June 25, 2024
Unexpected discovery of CRP analytical interference: A case reportVallauris Meslé, Eva Bories, Chloé Bost, et al.
Infectious Diseases Now|March 18, 2025
Early suPAR levels as a predictor of COVID-19 severity: A new tool for efficient patient triagePauline Nègre, Didier Tayac, Thibaut Jamme, et al.
Infectious Diseases Now|February 3, 2024
Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infectionGauthier Lignier, Caroline Camaré, Thibaut Jamme, et al.
La Revue De Medecine Interne|June 18, 2026
[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health]Guillaume Labarthe, Anne Galinier, Florence Rulquin, et al.
Diagnostic Microbiology and Infectious Disease|September 16, 2023
Evaluation of two anti-SARS-CoV-2 antibody immunoassays for monitoring patients on pre-exposure prophylaxisCamille Vellas, Chloé Dimeglio, Emma Joncour, et al.
Journal of Medical Virology|October 8, 2022
Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infectionMarion Migueres, Sabine Chapuy-Regaud, Marcel Miédougé, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 28, 2025
Optimization and stability evaluation of a pediatric spironolactone oral suspension: Formulation development and analytical validationRoxanne Desquines, Zoubeir Ramjaun, Acil Jaafar, et al.
Pageof 2